2.13
price up icon0.00%   0.00
after-market 시간 외 거래: 2.19 0.06 +2.82%
loading

Medicinova Inc 주식(MNOV)의 최신 뉴스

pulisher
Jan 02, 2025

MediciNova (NASDAQ:MNOV) Shares Pass Above 200-Day Moving Average – Time to Sell? - Defense World

Jan 02, 2025
pulisher
Jan 02, 2025

MediciNova (NASDAQ:MNOV) Stock Passes Above 200-Day Moving AverageHere's What Happened - MarketBeat

Jan 02, 2025
pulisher
Jan 02, 2025

MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews.com - MarketBeat

Jan 02, 2025
pulisher
Jan 02, 2025

MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 02, 2025
pulisher
Dec 25, 2024

StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV) - MarketBeat

Dec 25, 2024
pulisher
Dec 17, 2024

MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com - Defense World

Dec 17, 2024
pulisher
Dec 17, 2024

MediciNova (NASDAQ:MNOV) Stock Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Dec 17, 2024
pulisher
Dec 17, 2024

StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV) - MarketBeat

Dec 17, 2024
pulisher
Dec 12, 2024

MNOV: Encouraging Interim Analysis for Phase 2b/3 ALS Trial… - MSN

Dec 12, 2024
pulisher
Dec 09, 2024

MNOV: Encouraging Interim Analysis for Phase 2b/3 ALS Trial - Smartkarma

Dec 09, 2024
pulisher
Dec 09, 2024

MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com - Defense World

Dec 09, 2024
pulisher
Dec 06, 2024

Drug Trial Shows Positive Interim Results for ALS Treatment - Streetwise Reports

Dec 06, 2024
pulisher
Dec 05, 2024

MediciNova Presents Study Update and Interim Analysis of - GlobeNewswire

Dec 05, 2024
pulisher
Dec 05, 2024

MediciNova Reports Strong Interim Data from ALS Drug Trial, Shows Promising Correlations - StockTitan

Dec 05, 2024
pulisher
Dec 03, 2024

MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at D. Boral Capital - Defense World

Dec 03, 2024
pulisher
Dec 02, 2024

MediciNova stock undervalued? D. Boral sees upside in ALS & MS market opportunities - Investing.com India

Dec 02, 2024
pulisher
Dec 02, 2024

This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Dec 02, 2024
pulisher
Nov 29, 2024

Zacks sees 400% upside for MediciNova amid incoming damages from Sanofi/Novartis dispute - Kursiv Media

Nov 29, 2024
pulisher
Nov 26, 2024

MNOV: Monetary Damages Due Following Sanofi/Novartis Patent Dispute Settlement - Smartkarma

Nov 26, 2024
pulisher
Nov 25, 2024

MNOV: Monetary Damages Due Following Sanofi/Novartis Patent Dispute Settlement… - MSN

Nov 25, 2024
pulisher
Nov 21, 2024

MediciNova, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 21, 2024
pulisher
Nov 19, 2024

MediciNova reports progress in ALS and Long COVID trials - Investing.com

Nov 19, 2024
pulisher
Nov 19, 2024

MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders - GlobeNewswire

Nov 19, 2024
pulisher
Nov 19, 2024

MediciNova Partners with NIH for ALS Trial, Reports $42.3M Cash Position | MNOV Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 15, 2024

MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver - The Manila Times

Nov 15, 2024
pulisher
Nov 14, 2024

MediciNova Receives Notice of Allowance from United States - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

MediciNova Secures Key Patent for Diabetes Treatment MN-001 Through 2042 | MNOV Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

MediciNova stock hits 52-week high at $2.17 amid growth - Investing.com India

Nov 14, 2024
pulisher
Nov 14, 2024

MediciNova: Q3 Earnings Snapshot - Darien Times

Nov 14, 2024
pulisher
Nov 13, 2024

3 US Penny Stocks With Market Caps Over $40M To Consider - Simply Wall St

Nov 13, 2024
pulisher
Nov 12, 2024

MediciNova stock hits 52-week high at $2.17 amid growth By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 11, 2024

MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis - The Manila Times

Nov 11, 2024
pulisher
Nov 11, 2024

MediciNova Secures Major Settlement from Sanofi-Novartis Litigation, Boosts Clinical Pipeline | MNOV Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 11, 2024

Idiopathic Pulmonary Fibrosis Management Market Share and Size Report 2024-2031 - InsightAce Analytic

Nov 11, 2024
pulisher
Nov 07, 2024

MediciNova (NASDAQ:MNOV shareholders incur further losses as stock declines 11% this week, taking five-year losses to 80% - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

MediciNova (NASDAQ:MNOV) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Nov 07, 2024
$18.24
price down icon 0.60%
$21.47
price up icon 2.24%
$356.33
price down icon 1.08%
$42.18
price up icon 0.43%
$184.71
price up icon 0.49%
$115.79
price up icon 0.42%
자본화:     |  볼륨(24시간):